Evidence map›Paper›PMID 40937334›Full record

ArticleClinical kidney journal2025

The Swedish Renal Registry: a nationwide registry for chronic kidney disease of all stages.

Anne-Laure Faucon, Helena Rydell, Maria Stendahl, Gunilla Welander, Torbjörn Lundgren, Karl-Göran Prûtz, Staffan Schön, Ursa Bonnevier, Aline Kåveryd Hult, Håkan Hedman and 3 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anne-Laure FauconDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-6716-1157
Helena RydellDepartment of Nephrology, Karolinska University Hospital, Stockholm, Sweden.
Maria StendahlDepartment of Medicine, Ryhov Hospital, Region Jönköping, Sweden.
Gunilla WelanderDepartment of Nephrology, Karlstad Hospital, Karlstad, Sweden.
Torbjörn LundgrenDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Karl-Göran PrûtzSwedish Renal Registry, Region Jönköping, Jönköping, Sweden.
Staffan SchönSwedish Renal Registry, Region Jönköping, Jönköping, Sweden.
Ursa BonnevierDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Aline Kåveryd HultTransplant Centre, Sahlgrenska University Hospital, Göteborg, Sweden.
Håkan HedmanSwedish Renal Registry, Region Jönköping, Jönköping, Sweden.
Frida FondeliusDepartment of Endocrinology, Nephrology and Rheumatology, Skåne University Hospital, Lund, Sweden.
Mårten SegelmarkDepartment of Endocrinology, Nephrology and Rheumatology, Skåne University Hospital, Lund, Sweden.ORCID https://orcid.org/0000-0002-1221-0772
Marie EvansDepartment of Nephrology, Karolinska University Hospital, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-8650-5795

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: National registries that capture patients with chronic kidney disease (CKD) across all stages are scarce. We present here the Swedish Renal Registry (SRR), a nationwide prospective register covering the whole spectrum of CKD. Methods: Created in 1991, SRR enrolls CKD patients referred to adult nephrologist care (non-dialysis CKD [ND-CKD], kidney transplantation, maintenance dialysis), with an overall coverage of nearly all nephrology clinics in Sweden. SRR encompasses several interconnected databases in which longitudinal clinical, biological, kidney-related, patient-reported data, as well as provider-level information are collected. This report presents the design of the registry, as well as patients characteristics and temporal trends between 2008 and 2021. Results: A total of 45 590 new ND-CKD patients [72 years, 16 656 (36%) women, eGFR 26 ml/min per 1.73 m²], and 8829 incident kidney transplant recipients (51 years, 35% women) were enrolled in SRR between 2008 and 2021. SRR also included 16 034 new patients [68 years, 5420 (34%) women] on maintenance dialysis [70% hemodialysis (HD), 30% peritoneal dialysis (PD)]. Between 2015 and 2021, 4753 patients [59 years, 1884 (40%) women, eGFR 37 ml/min per 1.73 m²] had a registered kidney biopsy. We observed a decrease in HD incidence (69% to 60%, Conclusion: The SRR is a nationwide register which aims to contribute to address gaps in our understanding of CKD, to identify important challenges and health priorities, evaluate real-life clinical management and analyze international variations, improve health outcomes, improve quality of life, and reduce the burden of CKD.

Indexed as

chronic kidney diseaseclinical practicesdialysisregistrytransplantation

Identifiers

PMID40937334
PMCPMC12421726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.